Kintor Pharmaceutical Ltd (HK:9939) has released an update.
Kintor Pharmaceutical Limited has announced the launch of a new cosmetic product featuring their proprietary ingredient KX-826, aimed at treating androgenetic alopecia. The introduction of this anti-hair loss solution marks the company’s move from research and development into commercialization, with expectations of it significantly contributing to long-term revenue and cash flow. Kintor plans to expand its dermatological product line, enhance market reach, and expects to further commercialize its cosmetic products globally.
For further insights into HK:9939 stock, check out TipRanks’ Stock Analysis page.
